巴克莱:上调Certara评级

证券之星
09 May

巴克莱:上调Certara(CERT.US)评级,由持股观望调整至增持评级,目标价由11.00美元调整至14.00美元。Certara(CERT.US)公司简介:Certara Inc使用生物模拟软件和技术来加速药物向患者提供的速度,以改变传统药物的发现和开发。公司提供建模和仿真、监管科学和评估软件和服务,以帮助客户减少临床试验、加快监管批准和增加患者获得药物的机会。该公司在美洲拥有业务,这也是其...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10